Mandlig brystkræft: En oversigt

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Mandlig brystkræft : En oversigt. / Langer, Seppo W.; Krasnik, Mark; Hirsch, Fred R.; Dombernowsky, Per.

I: Ugeskrift for Laeger, Bind 158, Nr. 1, 1996, s. 37-40.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Langer, SW, Krasnik, M, Hirsch, FR & Dombernowsky, P 1996, 'Mandlig brystkræft: En oversigt', Ugeskrift for Laeger, bind 158, nr. 1, s. 37-40.

APA

Langer, S. W., Krasnik, M., Hirsch, F. R., & Dombernowsky, P. (1996). Mandlig brystkræft: En oversigt. Ugeskrift for Laeger, 158(1), 37-40.

Vancouver

Langer SW, Krasnik M, Hirsch FR, Dombernowsky P. Mandlig brystkræft: En oversigt. Ugeskrift for Laeger. 1996;158(1):37-40.

Author

Langer, Seppo W. ; Krasnik, Mark ; Hirsch, Fred R. ; Dombernowsky, Per. / Mandlig brystkræft : En oversigt. I: Ugeskrift for Laeger. 1996 ; Bind 158, Nr. 1. s. 37-40.

Bibtex

@article{66d68739efbd4e97827a9d8d21743c31,
title = "Mandlig brystkr{\ae}ft: En oversigt",
abstract = "Male breast cancer is a rare disease, making up less than 1% of all breast cancers. A review of the literature does not disclose major differences between male and female breast cancer regarding etiological, prognostic or diagnostic features. In male breast cancer endocrine therapy is more widely used, but there are otherwise no differences in the therapeutic strategies used.",
author = "Langer, {Seppo W.} and Mark Krasnik and Hirsch, {Fred R.} and Per Dombernowsky",
year = "1996",
language = "Tysk",
volume = "158",
pages = "37--40",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "1",

}

RIS

TY - JOUR

T1 - Mandlig brystkræft

T2 - En oversigt

AU - Langer, Seppo W.

AU - Krasnik, Mark

AU - Hirsch, Fred R.

AU - Dombernowsky, Per

PY - 1996

Y1 - 1996

N2 - Male breast cancer is a rare disease, making up less than 1% of all breast cancers. A review of the literature does not disclose major differences between male and female breast cancer regarding etiological, prognostic or diagnostic features. In male breast cancer endocrine therapy is more widely used, but there are otherwise no differences in the therapeutic strategies used.

AB - Male breast cancer is a rare disease, making up less than 1% of all breast cancers. A review of the literature does not disclose major differences between male and female breast cancer regarding etiological, prognostic or diagnostic features. In male breast cancer endocrine therapy is more widely used, but there are otherwise no differences in the therapeutic strategies used.

UR - http://www.scopus.com/inward/record.url?scp=0029689988&partnerID=8YFLogxK

M3 - Tidsskriftartikel

C2 - 8560622

AN - SCOPUS:0029689988

VL - 158

SP - 37

EP - 40

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 1

ER -

ID: 248231606